Company Filing History:
Years Active: 1995
Title: Mark A Calcagno: Innovator in Antiarrhythmic Agents
Introduction
Mark A Calcagno is a notable inventor based in Oxford, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiarrhythmic and antifibrillatory agents.
Latest Patents
Mark A Calcagno holds a patent for "4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents." This invention includes 4-oxocyclic ureas and their pharmaceutically acceptable salts and esters, which are designed to serve as effective treatments for heart rhythm disorders. The general structure of these compounds is defined in the patent specification.
Career Highlights
Calcagno is associated with Norwich Eaton Pharmaceuticals, Inc., where he has been instrumental in advancing pharmaceutical research and development. His work has focused on creating innovative solutions to complex medical challenges.
Collaborations
Some of his notable coworkers include Chia-Nien Yu and Stanford S Pelosi, Jr. Their collaborative efforts have contributed to the success of various projects within the company.
Conclusion
Mark A Calcagno's work in the pharmaceutical industry exemplifies the impact of innovation on healthcare. His patent for antiarrhythmic agents showcases his commitment to improving patient outcomes through scientific advancement.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.